- Home
- Free App Analytics
- InPen - Smart Insulin Pen
- InPen - Smart Insulin Pen Vs. Simplera™
InPen - Smart Insulin Pen vs Simplera™ Usage & Stats
InPen™ smart insulin pen helps you take the right amount of insulin, at the right time, by automatically tracking your doses and providing personalized insulin recommendations.
YOUR INSULIN PEN SHOULD WORK HARDER FOR YOU
Why are you still using an insulin pen that doesn’t track when you dose and how much you took? InPen smart insulin pen records all of your doses automatically. The app provides personalized insulin recommendations based on your glucose level, meal size, and insulin still active from prior injections.
Experience the freedom of pen therapy and save money.
ALL YOUR DATA IN ONE PLACE – AUTOMATICALLY
- Automatically records every dose
- Automatically syncs current Medtronic CGM data
- Automatically syncs Apple Health® integrated BG meters
- See the effect insulin and meals have on your glucose in a single integrated view
- View up to last 90 days of data
THE RIGHT AMOUNT OF INSULIN AT THE RIGHT TIME
- Personalized dose recommendations based on blood glucose, carb intake or meal size, and active insulin from prior doses
- Recommendations for when to eat carbs to prevent low glucose
- Carb counting, meal estimation, and fixed dose modes
- Reduced stress of insulin stacking and under-dosing
AVOID DANGEROUS LOWS AND FRUSTRATING HIGHS
- Accounts for active insulin from prior doses to help prevent overcorrecting
- Helps you avoid missed doses with long-acting and missed meal dose reminders
- Helps you correct high glucose between meals with confidence
- Alerts you if your insulin has gotten too hot or too cold
ADVANCED INSIGHTS FOR YOU AND YOUR HEALTH CARE PROVIDER
- Easily view and share advanced therapy reports
- Helps you assess the effectiveness of your long acting and meal doses
TODAY WIDGET
- View active insulin and recent doses from your lock screen
INPEN SMART INSULIN PEN
- Supports Lilly Humalog®, Lilly Lyumjev® or NovoRapid® and Fiasp® cartridges (not included)
- Unlocks Dose Calculator and Active insulin in the app when paired
- Works with multiple pens so you can keep one pen at home and one at school or work
Humalog® and Lyumjev® are registered trademarks of Eli Lilly and Company. NovoRapid® and Fiasp® are registered trademarks of Novo Nordisk A/S.
- Apple App Store
- Free
- Medical
Store Rank
- -
The Simplera™ continuous glucose monitoring (CGM) system helps people manage diabetes. CGM is a technology that lets users continuously view glucose values throughout the day, sends alerts for glucose events in a convenient and discreet manner on a mobile device, and shows the effects that diet, exercise, and medication can have on glucose levels.
The Simplera™ CGM uses an inserted Simplera™ sensor with Bluetooth™ wireless technology that converts small amounts of glucose from the interstitial fluid under the skin into an electronic signal. The Simplera™ sensor uses that signal to provide sensor glucose values to the Simplera™ system app on a compatible display device.
The Simplera™ app provides alerts based on sensor glucose (SG) levels and contains a user interface for entering data such as insulin, meals, exercise, blood glucose (BG) values, and uploading information to the CareLink™ Personal website. The Simplera™ app is available to download from the Apple® App Store™ and requires the Simplera™ sensor to function.
The Simplera™ CGM provides information that is used for diabetes management but does not provide any direct therapy. The Simplera™ CGM should only be used with supported mobile devices and operating systems. It is compatible with the Apple Watch™ which can display glucose values and receive system and SG alerts just like a mobile phone. In order to access the list of the supported mobile devices and operating systems, contact your local Medtronic representative.
To use the Simplera™ CGM, you will need the Simplera™ sensor as well as this app.
The clinical configuration of the app is intended for use in clinical research only. It is available only to individuals who have consented to take part in clinical research activities with Medtronic. Clinical studies where this app will be used will follow their own regulatory process and obtain requisite approvals.
IMPORTANT NOTE: This app will only work with Simplera™ sensor, which was specifically designed to communicate with your device via Bluetooth™. It will not connect to other Medtronic CGM transmitters.
This app store should not be used as your first point of contact to resolve technical or customer services issues. In order to protect your privacy and personal information, and promptly resolve any technical or customer services issues you are having with any Medtronic product, please contact your local Medtronic representative.
This app is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment.
©2025 Medtronic. All rights reserved. Medtronic, Medtronic logo, and Engineering the extraordinary are trademarks of Medtronic. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Apple, App Store, and Apple Watch are trademarks of Apple Inc., registered in the U.S. and other countries and regions.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license. Other trademarks and trade names are those of their respective owners.
- Apple App Store
- Free
- Medical
Store Rank
- -
InPen - Smart Insulin Pen vs. Simplera™ ranking comparison
Compare InPen - Smart Insulin Pen ranking trend in the past 28 days vs. Simplera™
Rank
No Data Available
InPen - Smart Insulin Pen vs. Simplera™ ranking by country comparison
Compare InPen - Smart Insulin Pen ranking trend in the past 28 days vs. Simplera™
All categories
No Data Available
Medical
Compare to any site with our free trial
January 16, 2026